Lycopodium Limited
LYOPF
$7.24
-$1.23-14.48%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 53.83M | 52.71M | 54.05M | 55.57M | 55.92M |
| Total Other Revenue | -3.50K | -3.40K | 3.60K | 3.70K | -415.10K |
| Total Revenue | 53.82M | 52.71M | 54.05M | 55.58M | 55.51M |
| Cost of Revenue | 40.74M | 39.89M | 37.44M | 38.50M | 43.24M |
| Gross Profit | 13.09M | 12.82M | 16.61M | 17.08M | 12.27M |
| SG&A Expenses | 523.70K | 512.80K | 561.80K | 577.70K | 455.10K |
| Depreciation & Amortization | 1.17M | 1.14M | 1.08M | 1.11M | 1.05M |
| Other Operating Expenses | 4.75M | 4.65M | 3.77M | 3.88M | 3.32M |
| Total Operating Expenses | 47.17M | 46.19M | 42.85M | 44.06M | 48.07M |
| Operating Income | 6.65M | 6.51M | 11.20M | 11.52M | 7.44M |
| Income Before Tax | 7.91M | 7.74M | 11.67M | 12.00M | 9.86M |
| Income Tax Expenses | 2.41M | 2.36M | 3.42M | 3.51M | 2.87M |
| Earnings from Continuing Operations | 5.49M | 5.38M | 8.25M | 8.48M | 6.99M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -59.00K | -57.80K | -25.10K | -25.80K | -157.30K |
| Net Income | 5.44M | 5.32M | 8.23M | 8.46M | 6.84M |
| EBIT | 6.65M | 6.51M | 11.20M | 11.52M | 7.44M |
| EBITDA | 7.10M | 7.15M | 12.28M | 12.62M | 7.86M |
| EPS Basic | 0.14 | 0.13 | 0.21 | 0.21 | 0.17 |
| Normalized Basic EPS | 0.12 | 0.12 | 0.18 | 0.19 | 0.15 |
| EPS Diluted | 0.14 | 0.13 | 0.21 | 0.21 | 0.17 |
| Normalized Diluted EPS | 0.12 | 0.12 | 0.18 | 0.19 | 0.15 |
| Average Basic Shares Outstanding | 39.72M | 39.72M | 39.76M | 39.76M | 39.74M |
| Average Diluted Shares Outstanding | 39.72M | 39.72M | 39.76M | 39.76M | 39.74M |
| Dividend Per Share | 0.08 | 0.08 | 0.03 | 0.03 | 0.13 |
| Payout Ratio | 23.42% | 23.42% | 62.96% | 62.96% | 70.87% |